神經調控設備市場：按設備類型、應用、最終用戶和地區分類

預計到2026年，神經調控設備市場規模將達215.9億美元，2033年將達到588.5億美元。預計從2026年到2033年，該市場將以15.4%的複合年成長率成長。

神經調控裝置利用電訊號、藥物或其他形式的能量來刺激神經，阻斷疼痛訊號到達大腦前的傳遞，進而緩解疼痛。神經調控裝置是植入式醫療設備，透過電刺激或藥物傳輸為某些慢性疾病提供治療方案。神經調控裝置主要分為五大類：脊髓刺激設備、深部腦部刺激器、迷走神經刺激設備、薦骨神經刺激器、胃電刺激設備。神經調控裝置會向神經和大腦傳遞電脈衝，用於治療聽力損失、慢性疼痛和帕金森氏症等疾病。電刺激療法用於治療脊髓損傷和神經系統疾病引起的肌肉無力。它能夠啟動電脈衝並將訊號傳遞至神經調控裝置中的電極，從而引起去極化，最終減輕疼痛並增強肌肉力量。各種類型的電刺激裝置旨在用於疼痛管理、肥胖和其他疾病的治療。

市場動態

預計監管機構產品核可的增加將推動全球神經調控設備市場在預測期內成長。例如，2023年4月19日，醫療科技公司BIOTRONIK宣布其脊髓刺激（SCS）系統「Prospera」已獲得美國食品藥物管理局（FDA）的核准。該系統採用全球首個多相刺激模式“RESONANCE”，並結合了以患者為中心的護理模式“Embrace One”。該模式透過提供自動化、客觀的日常遠端監測、持續管理和支持，實現預防性護理。此次核准標誌著該公司新業務部門「BIOTRONIK Neuro」的推出。

本次調查的主要特點

• 本研究揭示了各個細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數介紹了全球神經調節設備市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務績效和策略。
• 本研究涵蓋的主要公司包括Medtronic、BD、Livanova、Axonics、Cilatronics、Abbott、Bioventus、Neuronetics、NEVRO CORP、Integer Holdings Corporation、Biotronic、Neuropace、Neurometrics、Helius Medical Technologies 和 Synapse Biomedical。
• 本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 這份全球神經控制設備市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 透過分析全球神經調節設備市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 市場機遇
• 影響分析
• 監管指南
• 產品發布
• 主要進展
• PEST分析
• 波特的分析
• 監管趨勢
• 併購
• 製造商利潤
• 各國醫療保健成本

第4章 全球神經調控設備市場：依設備類型分類，2021-2033年

• 概述
• 脊髓刺激設備
• 深部腦部刺激裝置
• 薦椎神經刺激裝置
• 迷走神經刺激裝置
• 胃電刺激裝置

第5章 全球神經調控設備市場：依應用領域分類，2021-2033年

• 概述
• 疼痛管理
• 神經系統疾病和運動障礙的管理
• 肌肉骨骼疾病的治療
• 代謝和胃腸道管理
• 其他（例如，尿失禁管理）

第6章 全球神經調控設備市場：依最終使用者分類，2021-2033年

• 概述
• 醫院
• 門診手術中心
• 專科診所
• 其他（例如，物理治療中心）

第7章 全球神經調控設備市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• Medtronic
• BD
• LivaNova
  • Company Highlight
• Axonics, Inc.
  • Company Highlight
• ShiraTronics
• Abbott
• Bioventus
• Neuronetics
• NEVRO CORP
• Integer Holdings Corporation
• BIOTRONIK
• NeuroPace, Inc.
• NeuroMetrix, Inc.
• Helius Medical Technologies, Inc.
• Synapse Biomedical Inc.

第9章

• 調查方法
• 關於本公司

Neuromodulation Devices Market is estimated to be valued at USD 21.59 Bn in 2026 and is expected to reach USD 58.85 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.4% from 2026 to 2033.

Neuromodulation devices stimulate nerves with electrical signals, pharmaceutical agents, or other forms of energy neurostimulation that provides pain relief by blocking the transmission of pain signals before they reach the brain. Neuromodulation devices are implantable medical devices, which introduce therapeutic solutions to some chronic diseases through electric stimulation or medication. Neuromodulation devices are segmented into five major technologies, namely: spinal cord stimulation devices, deep brain stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices and gastric electric stimulation devices. Neuromodulation devices deliver electrical impulses to the nerves and the brain by treating disorders such as deafness, chronic pain, and Parkinson's disease. Lectrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has a property to activate electrical impulse and transmit signals to the electrodes of neuromodulation device, which causes depolarization and, in turn, reduces pain and improves the muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Market Dynamics

Increasing product approvals by regulatory authorities are expected to drive the global neuromodulation devices market growth over the forecast period. For instance, on April 19, 2023, BIOTRONIK, a medical technology company, announced the U.S. Food and Drug Administration (FDA) approval for Prospera, a Spinal Cord Stimulation (SCS) system. The system features RESONANCE, the first and multiphase stimulation paradigm, paired with Embrace One, a patient-centric care model that makes proactive care possible by offering automatic, objective, daily remote monitoring, and ongoing management and support. This approval marks the launch of the company's new business segment, BIOTRONIK Neuro.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neuromodulation devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Medtronic, BD, LivaNova, Axonics, Inc., ShiraTronics, Abbott, Bioventus, Neuronetics, NEVRO CORP, Integer Holdings Corporation, BIOTRONIK, NeuroPace, Inc., NeuroMetrix, Inc., Helius Medical Technologies, Inc., and Synapse Biomedical Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type upgrade, market expansion, and marketing tactics
• The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuromodulation devices market

Market Segmentation

• Global Neuromodulation Devices Market, Device Type (Revenue, USD Bn, 2021 - 2033)
• Spinal Cord Stimulation Devices
• Deep Brain Stimulation Devices
• Sacral Nerve Stimulation Devices
• Vagus Nerve Stimulation Devices
• Gastric Electric Stimulation Devices
• Global Neuromodulation Devices Market, Application (Revenue, USD Bn, 2021 - 2033)
• Pain Management
• Neurological and Movement Disorder Management
• Musculoskeletal Disorder Management
• Metabolism and GIT Management
• Others (Incontinence Management, etc.)
• Global Neuromodulation Devices Market, By End User (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers
• Specialized Clinics
• Others (Nursing Facilities, etc.)
• Global Neuromodulation Devices Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Global Neuromodulation Devices Market Companies
• Medtronic
• BD
• LivaNova
• Axonics, Inc.
• ShiraTronics
• Abbott
• Bioventus
• Neuronetics
• NEVRO CORP
• Integer Holdings Corporation
• BIOTRONIK
• NeuroPace, Inc.
• NeuroMetrix, Inc.
• Helius Medical Technologies, Inc.
• Synapse Biomedical Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Device Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trend Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Regulatory Guidelines
• Product launches
• Key Development
• PEST Analysis
• PORTER's Analysis
• Regulatory Scenario
• Mergers and Acquisitions
• Manufacturer Revenue
• Healthcare Spending by Country

4. Global Neuromodulation Devices Market, By Device Type, 2021 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Spinal Cord Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Deep Brain Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Sacral Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Vagus Nerve Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Gastric Electric Stimulation Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Neuromodulation Devices Market, By Application, 2021 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Neurological and Movement Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Musculoskeletal Disorder Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Metabolism and GIT Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Others (Incontinence Management, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Neuromodulation Devices Market, By End User, 2021 - 2033, (US$ Billion)

• Overview
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Specialized Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
• Others (Physiotherapy Centers, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Neuromodulation Devices Market, By Region, 2021 - 2033, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Billion)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Device Type, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Regions, 2021-2033, (US$ Billion)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Axonics, Inc.
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ShiraTronics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioventus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Neuronetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NEVRO CORP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Integer Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• BIOTRONIK
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroPace, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NeuroMetrix, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Helius Medical Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Synapse Biomedical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us